Performance measurement of intraoperative systolic arterial pressure to predict in-hospital mortality in adult liver transplantation

Hyung-Chul Lee, Ho-Geol Ryu, Chul-Woo Jung, Hyung-Chul Lee, Ho-Geol Ryu, Chul-Woo Jung

Abstract

Profound hypotension during liver transplantation is aggressively treated with vasopressors thus frequently unrevealed in a retrospective study. The relationship between concealed intraoperative hypotension and in-hospital mortality after liver transplantation was evaluated using performance measurement (PM) of systolic arterial pressure (SAP). Median performance error (MDPE), median absolute performance error (MDAPE), and wobble of SAP were calculated using preoperative SAP as the reference value, and prereperfusion and postreperfusion SAPs as measured values. Univariable and multivariable logistic regression analyses were performed using 6 PM parameters and 36 traditional SAP-derived parameters to predict in-hospital mortality. In-hospital mortality was 3.9% (22/569 cases). Prereperfusion MDAPE and postreperfusion wobble were the only significant SAP-derived predictors of in-hospital mortality. The area under receiver operating characteristic curve of prediction model was 0.769 (95% confidence interval 0.732-0.803, P < 0.001; sensitivity = 55%, specificity = 94%). Severe hypotension during liver transplantation is concealed by proactive vasopressor treatment thus traditional measures of hypotension generally fail to detect the masked hypotension in retrospective analysis. PM analysis of intraoperative SAP including prereperfusion MDAPE and postreperfusion wobble is most likely to detect treated and therefore concealed hypotension, and was able to independently and quantitatively predict in-hospital mortality after liver transplantation with high diagnostic specificity.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Systolic arterial pressure and performance error during prereperfusion and postreperfusion periods in survivors and non-survivors. Multiple line scatters show the means (dots) and standard deviations (error bars) of survivors and non-survivors. Horizontal lines are averages of intraoperative systolic arterial pressure in survivors (solid line) and non-survivors (dashed line) in Fig. 1A. The graphs start from the time of reperfusion then go towards the start or end of surgery, thus both ends of plot involves only a small number of patients. On average, systolic arterial pressures are a well-maintained around the average systolic arterial pressure in both the survivors and non-survivors during surgery (Fig. 1A). However, performance errors of non-survivors are more deviated and fluctuate above and below the target 0% level, compared to those of survivors (Fig. 1B).
Figure 2
Figure 2
Comparison of performance measures between survivors and non-survivors. Box plot shows median and interquartile range of prereperfusion and postreperfusion MDPE, MDAPE, and wobble in survivors and non-survivors. Upper and lower whiskers are maximum and minimum values, respectively. Round symbols show the 5th/95th percentile values. Prereperfusion and postreperfusion MDPE were similar between groups. However, prereperfusion and postreperfusion MDAPE, and postreperfusion wobble were significantly larger in non-survivors compared to survivors. *P < 0.001 vs prereperfusion values, †P < 0.001 vs survivors. Abbreviations: MDPE = median performance error, MDAPE = median absolute performance error.
Figure 3
Figure 3
ROC curves of the prediction models. Three ROC curves were built from the propensity scores of prediction models built with performance measures (PM model), MELD score (MELD model) or both (PM + MELD model), respectively. Addition of performance measurement parameters to the MELD model increased the diagnostic specificity of prediction model from 77% to 84%. The combined model has a significantly larger area under ROC curve compared to the PM model. *P = 0.007 vs PM model. Abbreviations: ROC = receiver operating characteristic; PM = performance measurement; MELD = model for end-stage liver disease.

References

    1. Wagener G, et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J. Cardiothorac. Vasc. Anesth. 2011;25:665–670. doi: 10.1053/j.jvca.2010.09.018.
    1. Harkin CP, Pagel PS, Kersten JR, Hettrick DA, Warltier DC. Direct negative inotropic and lusitropic effects of sevoflurane. Anesthesiology. 1994;81:156–67. doi: 10.1097/00000542-199407000-00022.
    1. Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant. Proc. 1987;19:54–5.
    1. Milan Z, Taylor C, Duncan B, Kedilaya H, Sylvester D. Statistical modeling of hemodynamic changes during orthotopic liver transplantation: Predictive value for outcome and effect of marginal donors. Transplant. Proc. 2011;43:1711–1715. doi: 10.1016/j.transproceed.2011.01.165.
    1. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J. Pharmacokinet. Biopharm. 1992;20:63–94. doi: 10.1007/BF01143186.
    1. Tassoudis V, et al. Impact of intraoperative hypotension on hospital stay in major abdominal surgery. J. Anesth. 2011;25:492–499. doi: 10.1007/s00540-011-1152-1.
    1. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth. Analg. 2005;100:4–10. doi: 10.1213/01.ANE.0000147519.82841.5E.
    1. Reich DL, et al. Association of Intraoperative Hypotension and Pulmonary Hypertension with Adverse Outcomes after Orthotopic Liver Transplantation. J. Cardiothorac. Vasc. Anesth. 2003;17:699–702. doi: 10.1053/j.jvca.2003.09.010.
    1. Hilmi I, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl. 2008;14:504–8. doi: 10.1002/lt.21381.
    1. Paugam-Burtz C, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors. Liver Transplant. 2009;15:522–529. doi: 10.1002/lt.21730.
    1. Bukowicka B, Akar RA, Olszewska A, Smoter P, Krawczyk M. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann. Transplant. 2013;16:26–30. doi: 10.12659/AOT.881861.
    1. Bijker JB, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107:213–20. doi: 10.1097/01.anes.0000270724.40897.8e.
    1. Warner MA, Monk TG. The impact of lack of standardized definitions on the specialty. Anesthesiology. 2007;107:198–199. doi: 10.1097/01.anes.0000271863.20091.60.
    1. Bijker JB, et al. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology. 2009;111:1217–26. doi: 10.1097/ALN.0b013e3181c14930.
    1. Bijker JB, et al. Intraoperative Hypotension and Perioperative Ischemic Stroke after General Surgery. Anesthesiology. 2012;116:658–664. doi: 10.1097/ALN.0b013e3182472320.
    1. Ramsay M. The reperfusion syndrome: have we made any progress? Liver Transpl. 2008;14:412–4. doi: 10.1002/lt.21418.
    1. Ryu HG, Jung CW, Lee CS, Lee J. Nafamostat mesilate attenuates postreperfusion syndrome during liver transplantation. Am. J. Transplant. 2011;11:977–983. doi: 10.1111/j.1600-6143.2011.03514.x.
    1. Agopian VG, et al. The Evolution of Liver Transplantation During 3 Decades. Ann. Surg. 2013;258:409–421. doi: 10.1097/SLA.0b013e3182a15db4.
    1. Hamaguchi Y, et al. Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation. Transplantation. 2016;100:1. doi: 10.1097/TP.0000000000001413.
    1. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am. J. Transplant. 2009;9:318–326. doi: 10.1111/j.1600-6143.2008.02491.x.
    1. O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445. doi: 10.1016/0016-5085(89)90081-4.
    1. Fukazawa K, Yamada Y, Gologorsky E, Arheart KL, Pretto EA. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. J. Cardiothorac. Vasc. Anesth. 2014;28:994–1002. doi: 10.1053/j.jvca.2014.02.017.
    1. Struys MM, et al. Comparison of closed-loop controlled administration of propofol using Bispectral Index as the controlled variable versus ‘standard practice’ controlled administration. Anesthesiology. 2001;95:6–17. doi: 10.1097/00000542-200107000-00007.
    1. Hemmerling TM, et al. Evaluation of a novel closed-loop total intravenous anaesthesia drug delivery system: A randomized controlled trial. Br. J. Anaesth. 2013;110:1031–1039. doi: 10.1093/bja/aet001.

Source: PubMed

3
Subscribe